|
ZDHHC6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.63859950450285E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.85050000165188E-10 |
| Normal-vs-Stage2 |
1.24730004102958E-09 |
| Normal-vs-Stage3 |
1.58819624118678E-11 |
| Normal-vs-Stage4 |
5.05417929730356E-12 |
| Stage1-vs-Stage2 |
5.837400E-01 |
| Stage1-vs-Stage3 |
1.963930E-02 |
| Stage1-vs-Stage4 |
6.777600E-04 |
| Stage2-vs-Stage3 |
3.986300E-02 |
| Stage2-vs-Stage4 |
4.442500E-03 |
| Stage3-vs-Stage4 |
2.567400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.31090044269899E-10 |
| Normal-vs-AfricanAmerican |
1.20800003333699E-09 |
| Normal-vs-Asian |
1.382980E-04 |
| Caucasian-vs-AfricanAmerican |
1.665180E-01 |
| Caucasian-vs-Asian |
2.316800E-01 |
| AfricanAmerican-vs-Asian |
1.018430E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.56130014367295E-10 |
| Normal-vs-Female |
8.87769968649366E-10 |
| Male-vs-Female |
2.420000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.07970349012044E-11 |
| Normal-vs-Extreme_Weight |
1.52159951305464E-10 |
| Normal-vs-Obese |
5.98070037938214E-10 |
| Normal-vs-Extreme_Obese |
5.53890000000168E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.189600E-01 |
| Normal_Weight-vs-Obese |
1.522970E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.020400E-01 |
| Extreme_Weight-vs-Obese |
1.613580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.891840E-01 |
| Obese-vs-Extreme_Obese |
6.953800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.09440037429931E-10 |
| Normal-vs-Age(41-60Yrs) |
8.60809978853183E-10 |
| Normal-vs-Age(61-80Yrs) |
3.43090000853863E-10 |
| Normal-vs-Age(81-100Yrs) |
1.45570222542801E-11 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.284200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.427200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.167370E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.783950E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.353800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.756200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.61269997356328E-09 |
| Normal-VS-Type2 PRCC |
1.77260428557702E-11 |
| Normal-VS-KIRP CIMP |
1.4128032077565E-11 |
| Normal-VS-Unclassified PRCC |
1.01230002158559E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.34710000002192E-06 |
| Type1 PRCC-VS-KIRP CIMP |
3.341100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.330200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.771000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.480800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.008000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.19699813897023E-11 |
| Normal-vs-N1 |
4.2880032857795E-11 |
| Normal-vs-N2 |
2.049800E-04 |
| N0-vs-N1 |
9.281000E-01 |
| N0-vs-N2 |
6.321800E-02 |
| N1-vs-N2 |
1.414630E-01 |
|
|
